![Scott Boyle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Boyle
Corporate Officer/Principal chez
C4 THERAPEUTICS, INC.
Fortune : 503 449 $ au 30/06/2026
Profil
Scott N.
Boyle is currently the Chief Business Officer at C4 Therapeutics, Inc., a position held since 2022.
Education history includes an undergraduate degree from Brigham Young University, a doctorate from Yale University, and an MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/02/2026 | 107 805 ( 0,1 % ) | 503 449 $ | 30/06/2026 |
Postes actifs de Scott Boyle
| Sociétés | Poste | Début |
|---|---|---|
| C4 THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2022 |
Formation de Scott Boyle
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Brigham Young University
 Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
